SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $46.02 | 52-week high | $48.76 |
Prev. close | $45.51 | 52-week low | $36.49 |
Day low | $45.54 | Volume | 4,710 |
Day high | $46.02 | Avg. volume | 42,902 |
50-day MA | $45.52 | Dividend yield | 1.53% |
200-day MA | $42.84 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Pharmaceuticals Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 159.44M |
Net Asset Value (NAV) | $45.55 |
Options? | Yes |
Total Holdings | 48 |
XPH Top Holdings
Symbol | Company | % of Total |
CORT | CORCEPT THERAPEUTICS INC | 4.92% |
LBPH | LONGBOARD PHARMACEUTICALS IN | 4.26% |
BMY | BRISTOL MYERS SQUIBB CO | 4.12% |
VTRS | VIATRIS INC | 3.97% |
ITCI | INTRA CELLULAR THERAPIES INC | 3.9% |
JAZZ | JAZZ PHARMACEUTICALS PLC | 3.85% |
AXSM | AXSOME THERAPEUTICS INC | 3.52% |
CTLT | CATALENT INC | 3.51% |
PRGO | PERRIGO CO PLC | 3.45% |
JNJ | JOHNSON + JOHNSON | 3.33% |
XPH Price Returns
1-mo | -1.46% |
3-mo | 4.67% |
6-mo | 15.37% |
1-year | 27.23% |
3-year | 0.12% |
5-year | 21.78% |
YTD | 11.94% |
2023 | 2.97% |
2022 | -9.83% |
2021 | -10.54% |
2020 | 14.68% |
2019 | 25.61% |
XPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |